Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001589776-26-000006

Director sold 20,000 shares at $12.00 ($240,000)

  • Director acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brughera Marco Maria · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $2.11 $42,200 20,000 D
2026-11-13 Sale : show line 2 in the form 10b5-1 −20,000 $12.00 $240,000 0 D
Open-market sales · 20,000 sh · avg $12.00 · $240,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-13 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −20,000 200,000 D
Loading xslF345X06/form4-11162026_041102.xml…